Geltis produces injectable polymer formulations for advanced drug delivery systems that are e liquid at room temperature and upon injection in the human body, they undergo a phase transition forming a 3D hydrogel structure. Geltis formulations possess a tunable composition, and are able to cover specific requirements. Geltis is a business to business company that supports pharmaceutical and medical companies in developing novel formulations.